The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice

Circulation Research

Volumn 121, Issue 3, 2017, Pages 234-243

  Haddad, Yacine ^a   Lahoute, Charlotte ^a   Clément, Marc ^b   Laurans, Ludivine ^a   Metghalchi, Sarvenaz ^a   Zeboudj, Lynda ^a   Giraud, Andreas ^a   Loyer, Xavier ^a   Vandestienne, Marie ^a   Wain Hobson, Julien ^a   Esposito, Bruno ^a   Potteaux, Stephane ^a   Ait Oufella, Hafid ^a   Tedgui, Alain ^a   Mallat, Ziad ^a,b   Taleb, Soraya ^a  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

atherosclerosis; dendritic cell; DNGR 1; inflammation; interleukin 10; necrosis

Indexed keywords

C TYPE LECTIN RECEPTOR; CD8ALPHA ANTIGEN; DENDRITIC CELL NK LECTIN GROUP RECEPTOR 1; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; LECTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG; CLEC9A PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HYPERCHOLESTEROLEMIA; INFLAMMATORY CELL; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; DENDRITIC CELL; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; DENDRITIC CELLS; INTERLEUKIN-10; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC;

EID: 85021078874     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.310960     Document Type: Article

References (45)

1. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol. 2000;157:1259-1268. doi:10.1016/S0002-9440(10)64641-X
2. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res. 2001;88:998-1003
3. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483-493. doi: 10.1111/joim.12406
4. Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118:653-667. doi: 10.1161/CIRCRESAHA.115.306256
5. Van Vré EA, Ait-Oufella H, Tedgui A, Mallat Z. Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:887-893. doi: 10.1161/ATVBAHA.111.224873
6. Thorp EB. Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease. Apoptosis. 2010;15:1124-1136. doi:10.1007/s10495-010-0516-6
7. Thorp E, Cui D, Schrijvers DM, Kuriakose G, Tabas I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/-mice. Arterioscler Thromb Vasc Biol. 2008;28:1421-1428. doi: 10.1161/ATVBAHA.108.167197
8. Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, Offenstadt G, Lesèche G, Cohen PL, Tedgui A, Mallat Z. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:1429-1431. doi: 10.1161/ATVBAHA.108.169078
9. Ait-Oufella H, Kinugawa K, Zoll J, et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 2007;115:2168-2177. doi: 10.1161/CIRCULATIONAHA.106.662080
10. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nat Immunol. 2006;7:1258-1265. doi: 10.1038/ni1417
11. Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I, Reis e Sousa C. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature. 2009;458:899-903. doi: 10.1038/nature07750
12. Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, Carlyle JR, Reis e Sousa C. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest. 2008;118:2098-2110. doi: 10.1172/JCI34584
13. Huysamen C, Willment JA, Dennehy KM, Brown GD. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem. 2008;283:16693-16701. doi: 10.1074/jbc.M709923200
14. Silvestre JS, Théry C, Hamard G, et al. Lactadherin promotes VEGFdependent neovascularization. Nat Med. 2005;11:499-506. doi: 10.1038/nm1233
15. Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J, Yoshimura A, Tedgui A, Mallat Z. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med. 2009;206:2067-2077. doi: 10.1084/jem.20090545
16. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang J, Offenstadt G, Combadière C, Rénia L, Johnson JL, Tharaux PL, Tedgui A, Mallat Z. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010;120:422-432. doi: 10.1172/JCI38136
17. Caminschi I, Proietto AI, Ahmet F, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 2008;112:3264-3273. doi: 10.1182/blood-2008-05-155176
18. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest. 2002;109:745-753. doi: 10.1172/JCI7272
19. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39:806-818. doi: 10.1016/j.immuni.2013.10.010
20. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304:1147-1150. doi: 10.1126/science.1094359
21. Ait-Oufella H, Kinugawa K, Zoll J, et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 2007;115:2168-2177. doi: 10.1161/CIRCULATIONAHA.106.662080
22. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-581. doi: 10.1152/physrev.00024.2005
23. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003;112:1342-1350. doi: 10.1172/JCI18607
24. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, Tedgui A, Mallat Z, Groux H. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. 2003;102:4052-4058. doi: 10.1182/blood-2003-05-1729
25. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999;85:e17-e24
26. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002;90:1064-1071
27. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H, Tedgui A, Mallat Z. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:1474-1478. doi:10.1161/01.ATV.0000134378.86443.cd
28. Choi JH, Cheong C, Dandamudi DB, Park CG, Rodriguez A, Mehandru S, Velinzon K, Jung IH, Yoo JY, Oh GT, Steinman RM. Flt3 signalingdependent dendritic cells protect against atherosclerosis. Immunity. 2011;35:819-831. doi: 10.1016/j.immuni.2011.09.014
29. Legein B, Janssen EM, Theelen TL, et al. Ablation of CD8(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice. Sci Rep. 2015;5:15414. doi: 10.1038/srep15414
30. Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, Rogers NC, Schulz O, Sancho D, Reis e Sousa C. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest. 2012;122:1615-1627. doi: 10.1172/JCI60644
31. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-742. doi:10.1038/39614
32. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605-617
33. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355. doi: 10.1016/j.cell.2011.04.005
34. Clément M, Basatemur G, Masters L, Baker L, Bruneval P, Iwawaki T, Kneilling M, Yamasaki S, Goodall J, Mallat Z. Necrotic cell sensor Clec4e promotes a proatherogenic macrophage phenotype through activation of the unfolded protein response. Circulation. 2016;134:1039-1051. doi:10.1161/CIRCULATIONAHA.116.022668
35. Rocha DM, Caldas AP, Oliveira LL, Bressan J, Hermsdorff HH. Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis. 2016;244:211-215. doi: 10.1016/j.atherosclerosis.2015.11.015
36. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest. 2001;108:251-259. doi: 10.1172/JCI11380
37. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1997;94:4642-4646
38. Tsaousi A, Hayes EM, Di Gregoli K, Bond AR, Bevan L, Thomas AC, Newby AC. Plaque size is decreased but M1 macrophage polarization and rupture related metalloproteinase expression are maintained after deleting T-bet in apoE null mice. PLoS One. 2016;11:e0148873. doi: 10.1371/journal.pone.0148873
39. Schraml BU, van Blijswijk J, Zelenay S, Whitney PG, Filby A, Acton SE, Rogers NC, Moncaut N, Carvajal JJ, Reis e Sousa C. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell. 2013;154:843-858. doi: 10.1016/j. cell.2013.07.014
40. Han P, Fujii T, Iborra S, Yamada Y, Huotari J, Schulz O, Ahrens S, Kjar S, Way M, Sancho D, Namba K, Reis e Sousa C. Structure of the complex of F-actin and DNGR-1, a C-type lectin receptor involved in dendritic cell cross-presentation of dead cell-associated antigens. Immunity. 2015;42:839-849. doi: 10.1016/j.immuni.2015.04.009
41. Elhage R, Gourdy P, Brouchet L, Jawien J, Fouque MJ, Fiévet C, Huc X, Barreira Y, Couloumiers JC, Arnal JF, Bayard F. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol. 2004;165:2013-2018
42. Kolbus D, Ljungcrantz I, Söderberg I, Alm R, Björkbacka H, Nilsson J, Fredrikson GN. TAP1-deficiency does not alter atherosclerosis development in Apoe-/-mice. PLoS One. 2012;7:e33932. doi: 10.1371/journal. pone.0033932
43. Cochain C, Koch M, Chaudhari SM, Busch M, Pelisek J, Boon L, Zernecke A. CD8+ T cells regulate monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice. Circ Res. 2015;117:244-253. doi:10.1161/CIRCRESAHA.117.304611
44. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, Witztum JL, Bae YS, Miller YI. Lipoprotein accumulation in macrophages via tolllike receptor-4-dependent fluid phase uptake. Circ Res. 2009;104:1355-1363. doi: 10.1161/CIRCRESAHA.108.192880
45. Yin H, Zhou H, Kang Y, Zhang X, Duan X, Alnabhan R, Liang S, Scott DA, Lamont RJ, Shang J, Wang H. Syk negatively regulates TLR4-mediated IFN and IL-10 production and promotes inflammatory responses in dendritic cells. Biochim Biophys Acta. 2016;1860:588-598. doi: 10.1016/j. bbagen.2015.12.012.